Beckman Coulter unveils new tabletop hematology analyzer

By staff writers

January 26, 2021 -- Beckman Coulter has introduced the DxH 560 AL, a tabletop hematology analyzer targeted at small and medium-sized labs.

The DxH 560 AL features auto-loading functionality, as well as closed tube aspiration and walkaway capabilities, according to the company. Users can also continuously add up to 50 samples to the analyzer, which can provide results in 60 sec or less from a sample volume of 17 µL -- less than a drop of blood, Beckman Coulter said.

Beckman Coulter
Beckman Coulter's DxH 560 lab analyzer. Image courtesy of Beckman Coulter.

The analyzer also includes privacy and security features such as a customizable user login, paperless data management, and traceable automated timeouts to guard patient electronic personal health information, the firm said.

Beckman Coulter launches high-throughput COVID-19 assay
Beckman Coulter has debuted a new COVID-19 test, the Access SARS-CoV-2 antigen assay, which the company said is cost-effective and has high throughput.
Beckman Coulter nabs EUA for COVID-19 IgM assay
The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to Beckman Coulter's Access SARS-CoV-2 immunoglobulin M (IgM) assay,...
FDA grants Beckman Coulter EUA for assay test
The U.S. Food and Drug Administration (FDA) has awarded Beckman Coulter emergency use authorization (EUA) for its Access Interleukin-6 assay.
Top companies earn 80% of revenue in IVD market
Most of the revenue in the IVD market is generated by fewer than 20 companies, according to a recent report by IVD market research firm Kalorama Information,...
Beckman Coulter releases COVID-19 antibody test
Beckman Coulter has released its Access SARS-CoV-2 Immunoglobulin M assay, a new antibody test for the novel coronavirus. The assay targets antibodies...

Copyright © 2021

Last Updated ls 1/26/2021 4:30:51 PM